Close Menu

stock offering

The firm earlier this week also filed a prospectus for the sale of nearly 2 million shares of common stock that may be reoffered or resold from time to time by certain selling stockholders.

The firm is offering an additional 500,000 shares of Class A stock, bringing the total to 4 million shares, offered at $110 per share.

The company is selling 4,166,666 shares of its common stock at a price of $60 per share in the offering, which is expected to close Sept. 15.

The firm also expects to grant the underwriters a 30-day option to purchase up to an additional $37.5 million worth of shares of its common stock.

The single-cell and spatial genomics firm is seeking to raise more money from the markets a year after its $410.8 million IPO.

The company's contract with the NIH offered $12 million total and after initial test verification, Fluidigm will receive approximately $11 million.

The sequencing firm is offering 19.4 million shares of common stock at $4.47 per share and plans to use the proceeds for product launches, among other uses.

The company priced about 6.6 million shares of its common stock at $19 per share, and is offering underwriters an option to purchase additional shares from a selling stockholder.

The company said that it has priced a public offering of 2,651,108 shares of its common stock at $32 per share.

Pages

Howard Hughes Medical Institute will be requiring its researchers to publish their work so it is immediately accessible to the public, ScienceInsider writes.

The Huffington Post reports that Francis Collins, the director of the US National Institutes of Health, has urged Americans to recommit to reason.

About 150 million rapid coronavirus tests purchased by the US federal government are to be distributed to nursing homes, colleges, and the states, according to the New York Times.

In Nature this week: multi-omic analysis of Alzheimer's disease brain samples, de novo assembly of a diploid potato, and more.